Translating A Non-Viral Anti-Inflammatory Gene Therapy into ALS Mouse Models & Preparing for First In-Human Studies

Time: 1:10 pm
day: Day Two Track A PM


  • Developing a unique therapeutic approach of targeting IL-10 with a non-viral gene therapy
  • Showcasing preclinical data of anti-inflammatory effect in TDP-43 mouse models
  • Outlining future directions for translation into phase 1 clinical study